AR016349A1 - COMBINACIoN FARMACÉUTICA DE UNA TIAZOLIDINDIONA, UN SECRETAGOGO DE INSULINA Y UN AGENTE ANTIHIPERGLUCEMIANTE DE BIGUADINA, Y USO DE LOS MISMOS EN LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE LA DIABETES MELLITUS Y CONDICIONES ASOCIADAS A LA MISMA - Google Patents

COMBINACIoN FARMACÉUTICA DE UNA TIAZOLIDINDIONA, UN SECRETAGOGO DE INSULINA Y UN AGENTE ANTIHIPERGLUCEMIANTE DE BIGUADINA, Y USO DE LOS MISMOS EN LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE LA DIABETES MELLITUS Y CONDICIONES ASOCIADAS A LA MISMA

Info

Publication number
AR016349A1
AR016349A1 ARP980103481A ARP980103481A AR016349A1 AR 016349 A1 AR016349 A1 AR 016349A1 AR P980103481 A ARP980103481 A AR P980103481A AR P980103481 A ARP980103481 A AR P980103481A AR 016349 A1 AR016349 A1 AR 016349A1
Authority
AR
Argentina
Prior art keywords
insulin
appropriate
thiazolidine
dione
benzyl
Prior art date
Application number
ARP980103481A
Other languages
English (en)
Spanish (es)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR016349A1 publication Critical patent/AR016349A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP980103481A 1997-07-18 1998-07-16 COMBINACIoN FARMACÉUTICA DE UNA TIAZOLIDINDIONA, UN SECRETAGOGO DE INSULINA Y UN AGENTE ANTIHIPERGLUCEMIANTE DE BIGUADINA, Y USO DE LOS MISMOS EN LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE LA DIABETES MELLITUS Y CONDICIONES ASOCIADAS A LA MISMA AR016349A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715295A GB9715295D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
AR016349A1 true AR016349A1 (es) 2001-07-04

Family

ID=10816167

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980103481A AR016349A1 (es) 1997-07-18 1998-07-16 COMBINACIoN FARMACÉUTICA DE UNA TIAZOLIDINDIONA, UN SECRETAGOGO DE INSULINA Y UN AGENTE ANTIHIPERGLUCEMIANTE DE BIGUADINA, Y USO DE LOS MISMOS EN LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE LA DIABETES MELLITUS Y CONDICIONES ASOCIADAS A LA MISMA

Country Status (39)

Country Link
EP (1) EP1001783B1 (enEXAMPLES)
JP (2) JP2001510159A (enEXAMPLES)
KR (1) KR100671918B1 (enEXAMPLES)
CN (1) CN1264303A (enEXAMPLES)
AP (1) AP1352A (enEXAMPLES)
AR (1) AR016349A1 (enEXAMPLES)
AT (1) ATE305790T1 (enEXAMPLES)
AU (1) AU8448898A (enEXAMPLES)
BG (1) BG64785B1 (enEXAMPLES)
BR (1) BR9810445A (enEXAMPLES)
CA (1) CA2296653C (enEXAMPLES)
CO (1) CO4940420A1 (enEXAMPLES)
CY (1) CY1105254T1 (enEXAMPLES)
DE (1) DE69831808T2 (enEXAMPLES)
DK (1) DK1001783T3 (enEXAMPLES)
DZ (1) DZ2562A1 (enEXAMPLES)
EA (1) EA003021B1 (enEXAMPLES)
ES (1) ES2251093T3 (enEXAMPLES)
GB (1) GB9715295D0 (enEXAMPLES)
HU (1) HUP0003629A3 (enEXAMPLES)
ID (1) ID24211A (enEXAMPLES)
IL (1) IL134046A0 (enEXAMPLES)
IN (1) IN189275B (enEXAMPLES)
MA (1) MA24607A1 (enEXAMPLES)
MY (1) MY155219A (enEXAMPLES)
NO (1) NO325727B1 (enEXAMPLES)
NZ (2) NZ501164A (enEXAMPLES)
OA (1) OA11279A (enEXAMPLES)
PE (1) PE99599A1 (enEXAMPLES)
PL (2) PL197844B1 (enEXAMPLES)
SA (1) SA98190468B1 (enEXAMPLES)
SI (1) SI1001783T1 (enEXAMPLES)
SK (1) SK285484B6 (enEXAMPLES)
TR (1) TR200000134T2 (enEXAMPLES)
TW (1) TW505516B (enEXAMPLES)
UA (1) UA70303C2 (enEXAMPLES)
UY (1) UY25102A1 (enEXAMPLES)
WO (1) WO1999003477A1 (enEXAMPLES)
ZA (1) ZA986363B (enEXAMPLES)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
PL347634A1 (en) * 1998-11-12 2002-04-22 Smithkline Beecham Plc Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
SE9902918D0 (sv) * 1999-08-13 1999-08-13 Pharmacia & Upjohn Ab Methods for identification of compounds stimulating insulin secretion
WO2001035940A2 (en) * 1999-11-16 2001-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride
MY125516A (en) * 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
FR2812547B1 (fr) * 2000-08-04 2002-10-31 Lipha Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
PL362687A1 (en) 2001-01-12 2004-11-02 Sun Pharmaceutical Industries Limited Spaced drug delivery system
ITFI20010126A1 (it) * 2001-07-09 2003-01-09 Molteni & C Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide
WO2003005995A1 (en) * 2001-07-10 2003-01-23 Aeropharm Technology Incorporated Core formulation comprising pioglitazone hydrochloride and a biguanide
PL376577A1 (pl) 2002-06-17 2006-01-09 Themis Laboratories Private Limited Wielowarstwowe tabletki zawierające tiazolidinedion i biguanidy oraz metody ich wytwarzania
KR20100137023A (ko) * 2002-09-20 2010-12-29 안드렉스 랩스 엘엘씨 약제학적 정제
UA80991C2 (en) 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
PL1677792T3 (pl) 2003-10-31 2016-05-31 Takeda Pharmaceuticals Co Stały preparat zawierający pioglitazon, glimepiryd i ester polioksyetylenosorbitanu z kwasem tłuszczowym
MXPA05010977A (es) * 2005-10-12 2007-04-11 Abdala Leopoldo Espinosa Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus.
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
CN101417130B (zh) * 2007-10-22 2010-10-06 鲁南制药集团股份有限公司 一种治疗ⅱ型糖尿病及其并发症的药物组合物
KR102176069B1 (ko) * 2017-10-20 2020-11-09 주식회사 노브메타파마 아연염, 시클로-히스프로 및 항당뇨 약물을 유효성분으로 함유하는 당뇨병 예방 또는 치료용 약학적 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
FI904414A7 (fi) * 1988-03-08 1990-09-07 Pfizer Tiatsolidiinidioni-hypoglykeemisesti vaikuttavat aineet
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
ATE151634T1 (de) * 1991-08-26 1997-05-15 Upjohn Co Flüssiges nahrungsmittel, das 3- guanidinopropionsäure enthält
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
AU8539298A (en) * 1997-06-18 1999-01-04 Smithkline Beecham Plc Treatment of diabetes with thiazolidinedione and sulphonylurea

Also Published As

Publication number Publication date
OA11279A (en) 2003-07-31
KR20010021947A (ko) 2001-03-15
UA70303C2 (uk) 2004-10-15
PL338126A1 (en) 2000-09-25
KR100671918B1 (ko) 2007-01-22
NZ511608A (en) 2002-12-20
MA24607A1 (fr) 1999-04-01
SK285484B6 (sk) 2007-02-01
AU8448898A (en) 1999-02-10
BG64785B1 (bg) 2006-04-28
PL198017B1 (pl) 2008-05-30
EP1001783B1 (en) 2005-10-05
EA200000139A1 (ru) 2000-06-26
PE99599A1 (es) 1999-12-18
NO20000228L (no) 2000-01-17
NO325727B1 (no) 2008-07-07
SK592000A3 (en) 2000-09-12
CY1105254T1 (el) 2010-03-03
NO20000228D0 (no) 2000-01-17
ES2251093T3 (es) 2006-04-16
BR9810445A (pt) 2000-09-05
WO1999003477A1 (en) 1999-01-28
ZA986363B (en) 2000-01-17
TR200000134T2 (tr) 2000-09-21
ID24211A (id) 2000-07-13
CA2296653A1 (en) 1999-01-28
AP1352A (en) 2004-12-24
DE69831808T2 (de) 2006-07-06
TW505516B (en) 2002-10-11
DZ2562A1 (fr) 2003-02-15
CA2296653C (en) 2007-10-02
MY155219A (en) 2015-09-30
CO4940420A1 (es) 2000-07-24
JP2001510159A (ja) 2001-07-31
HK1028550A1 (en) 2001-02-23
UY25102A1 (es) 2000-12-29
HUP0003629A3 (en) 2003-04-28
ATE305790T1 (de) 2005-10-15
PL197844B1 (pl) 2008-05-30
SI1001783T1 (sl) 2006-02-28
CN1264303A (zh) 2000-08-23
JP2005213273A (ja) 2005-08-11
EP1001783A1 (en) 2000-05-24
IL134046A0 (en) 2001-04-30
SA98190468B1 (ar) 2007-01-20
NZ501164A (en) 2001-06-29
DK1001783T3 (da) 2006-02-06
EA003021B1 (ru) 2002-12-26
HUP0003629A2 (hu) 2001-07-30
BG104135A (en) 2000-10-31
IN189275B (enEXAMPLES) 2003-01-25
GB9715295D0 (en) 1997-09-24
AP2000001733A0 (en) 2000-03-31
DE69831808D1 (de) 2006-02-16

Similar Documents

Publication Publication Date Title
AR016349A1 (es) COMBINACIoN FARMACÉUTICA DE UNA TIAZOLIDINDIONA, UN SECRETAGOGO DE INSULINA Y UN AGENTE ANTIHIPERGLUCEMIANTE DE BIGUADINA, Y USO DE LOS MISMOS EN LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE LA DIABETES MELLITUS Y CONDICIONES ASOCIADAS A LA MISMA
CA2345524C (en) Combinations for diabetes which contain a sulfonylurea, a glitazone and a biguanide
MY129897A (en) Use of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2, 4-dione and metformin for the treatment of diabetes mellitus
HRP20020994A2 (en) Combinations of depeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabete mellitus
Kiayias et al. Rosiglitazone in combination with glimepiride plus metformin in type 2 diabetic patients
CA2297115A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
CO4940489A1 (es) Nuevo metodo de tratamiento cines asociadas a la misma en mamiferos
KR20010075698A (ko) 베타 아고니스트 및 추가의 항당뇨병제를 포함하는 병용제
UA67743C2 (uk) Фармацевтична композиція, що містить тіазолідиндіон і сульфонілсечовину, для лікування діабету
US20020016287A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
CZ20033233A3 (cs) Farmaceutická kombinace
MXPA01004826A (en) Combinations comprising a beta-agonist and a further antidiabetic agent
CZ20033234A3 (cs) Farmaceutická kombinace
MXPA00000633A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
US20030092750A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
ZA200103792B (en) Combinations comprising a beta-agonist and a further antidiabetic agent.
CZ20033235A3 (cs) Farmaceutická kombinace
MXPA00000655A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
MXPA00000631A (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
HK1028550B (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide

Legal Events

Date Code Title Description
FB Suspension of granting procedure